End of Period Subscribers of 3.8 million, including 81 thousand End of Period Clinical Subscribers Revenues of 202.1millionGrossmarginof67.935.9 million; excluding the net impact of restructuring charges related to prior year restructuring plans, adjusted operating income of 37.9millionProvidesupdatetofullyearfiscal2024guidanceAnnounces2024RestructuringPlanthatisexpectedtoresultin100 million of annual run-rate cost savings related to strategic streamlining ...